BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 21087085)

  • 1. Murine aldo-keto reductase family 1 subfamily B: identification of AKR1B8 as an ortholog of human AKR1B10.
    Joshi A; Rajput S; Wang C; Ma J; Cao D
    Biol Chem; 2010 Dec; 391(12):1371-8. PubMed ID: 21087085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells.
    Ma J; Yan R; Zu X; Cheng JM; Rao K; Liao DF; Cao D
    J Biol Chem; 2008 Feb; 283(6):3418-3423. PubMed ID: 18056116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human and rodent aldo-keto reductases from the AKR1B subfamily and their specificity with retinaldehyde.
    Ruiz FX; Moro A; Gallego O; Ardèvol A; Rovira C; Petrash JM; Parés X; Farrés J
    Chem Biol Interact; 2011 May; 191(1-3):199-205. PubMed ID: 21329680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldo-keto reductase family 1 member B8 is secreted via non-classical pathway.
    Tang Z; Xia C; Huang R; Li X; Wang WC; Guo W; Duan L; Luo W; Cao D; Luo DX
    Int J Clin Exp Pathol; 2014; 7(7):3791-9. PubMed ID: 25120755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldo-keto reductase family 1 member B10 promotes cell survival by regulating lipid synthesis and eliminating carbonyls.
    Wang C; Yan R; Luo D; Watabe K; Liao DF; Cao D
    J Biol Chem; 2009 Sep; 284(39):26742-8. PubMed ID: 19643728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification, cloning and regulation of cDNA encoding aldo-keto reductase 1B7 in the adrenal gland of two Saharan rodents Meriones libycus (Libyan jird) and Gerbillus gerbillus (gerbil).
    Mataoui-Mazari H; Amirat Z; Khammar F; Martinez A
    Gen Comp Endocrinol; 2011 Dec; 174(3):292-300. PubMed ID: 21963864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of AKR1B10 and AKR1B8 in the pathogenesis of non-alcoholic steatohepatitis (NASH) in mouse.
    Rajak S; Gupta P; Anjum B; Raza S; Tewari A; Ghosh S; Tripathi M; Singh BK; Sinha RA
    Biochim Biophys Acta Mol Basis Dis; 2022 Apr; 1868(4):166319. PubMed ID: 34954342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
    Takemura M; Endo S; Matsunaga T; Soda M; Zhao HT; El-Kabbani O; Tajima K; Iinuma M; Hara A
    J Nat Prod; 2011 May; 74(5):1201-6. PubMed ID: 21561086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldo-Keto Reductases as Early Biomarkers of Hepatocellular Carcinoma: A Comparison Between Animal Models and Human HCC.
    Torres-Mena JE; Salazar-Villegas KN; Sánchez-Rodríguez R; López-Gabiño B; Del Pozo-Yauner L; Arellanes-Robledo J; Villa-Treviño S; Gutiérrez-Nava MA; Pérez-Carreón JI
    Dig Dis Sci; 2018 Apr; 63(4):934-944. PubMed ID: 29383608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldo-keto reductase family 1, member B10 is secreted through a lysosome-mediated non-classical pathway.
    Luo DX; Huang MC; Ma J; Gao Z; Liao DF; Cao D
    Biochem J; 2011 Aug; 438(1):71-80. PubMed ID: 21585341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes.
    Spite M; Baba SP; Ahmed Y; Barski OA; Nijhawan K; Petrash JM; Bhatnagar A; Srivastava S
    Biochem J; 2007 Jul; 405(1):95-105. PubMed ID: 17381426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of aldo-keto reductase AKR1B10 as a selective target for modification and inhibition by prostaglandin A(1): implications for antitumoral activity.
    Díez-Dacal B; Gayarre J; Gharbi S; Timms JF; Coderch C; Gago F; Pérez-Sala D
    Cancer Res; 2011 Jun; 71(12):4161-71. PubMed ID: 21507934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of aldo-keto reductase family 1 member B10 on the risk of hepatitis C virus-related hepatocellular carcinoma.
    Sato S; Genda T; Ichida T; Murata A; Tsuzura H; Narita Y; Kanemitsu Y; Ishikawa S; Kikuchi T; Mori M; Hirano K; Iijima K; Wada R; Nagahara A; Watanabe S
    J Gastroenterol Hepatol; 2016 Jul; 31(7):1315-22. PubMed ID: 26758591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic studies of AKR1B10, human aldose reductase-like protein: endogenous substrates and inhibition by steroids.
    Endo S; Matsunaga T; Mamiya H; Ohta C; Soda M; Kitade Y; Tajima K; Zhao HT; El-Kabbani O; Hara A
    Arch Biochem Biophys; 2009 Jul; 487(1):1-9. PubMed ID: 19464995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas.
    Fukumoto S; Yamauchi N; Moriguchi H; Hippo Y; Watanabe A; Shibahara J; Taniguchi H; Ishikawa S; Ito H; Yamamoto S; Iwanari H; Hironaka M; Ishikawa Y; Niki T; Sohara Y; Kodama T; Nishimura M; Fukayama M; Dosaka-Akita H; Aburatani H
    Clin Cancer Res; 2005 Mar; 11(5):1776-85. PubMed ID: 15755999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired self-renewal and increased colitis and dysplastic lesions in colonic mucosa of AKR1B8-deficient mice.
    Shen Y; Ma J; Yan R; Ling H; Li X; Yang W; Gao J; Huang C; Bu Y; Cao Y; He Y; Wan L; Zu X; Liu J; Huang MC; Stenson WF; Liao DF; Cao D
    Clin Cancer Res; 2015 Mar; 21(6):1466-76. PubMed ID: 25538260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of AKR1B16, a novel mouse aldo-keto reductase.
    Giménez-Dejoz J; Weber S; Barski OA; Möller G; Adamski J; Parés X; Porté S; Farrés J
    Chem Biol Interact; 2017 Oct; 276():182-193. PubMed ID: 28322781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and promoter characterization of aldo-keto reductase family 1 B10 gene.
    Liu Z; Zhong L; Krishack PA; Robbins S; Cao JX; Zhao Y; Chung S; Cao D
    Gene; 2009 May; 437(1-2):39-44. PubMed ID: 19236911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AKR1B10, a transcriptional target of p53, is downregulated in colorectal cancers associated with poor prognosis.
    Ohashi T; Idogawa M; Sasaki Y; Suzuki H; Tokino T
    Mol Cancer Res; 2013 Dec; 11(12):1554-63. PubMed ID: 24140838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: Implication for cancer intervention.
    Yan R; Zu X; Ma J; Liu Z; Adeyanju M; Cao D
    Int J Cancer; 2007 Nov; 121(10):2301-6. PubMed ID: 17597105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.